Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 17, 2024 - Issue
Submit an article Journal homepage
47
Views
0
CrossRef citations to date
0
Altmetric
RESPONSE TO LETTER

Response to: “Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?” [Response to Letter]

Cristina Montrasio1 Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8276-3663
ORCID Icon,
Stefania Cheli1 Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, ItalyORCID Iconhttps://orcid.org/0000-0002-2837-5248
ORCID Icon &
Emilio Clementi2 Clinical Pharmacology Unit, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, Università degli Studi di Milano, Milan, Italy;3 Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Italy
Pages 51-52 | Received 22 Dec 2023, Accepted 09 Jan 2024, Published online: 31 Jan 2024

References

  • Montrasio C, Cheli S, Clementi E. Pharmacogenetic practice of anticancer drugs: multiple approaches for an accurate and comprehensive genotyping. Pharmgenomics Pers Med. 2023;16:739–746. doi:10.2147/PGPM.S412430
  • de With M, Sadlon A, Cecchin E, et al.; The Working Group on the Implementation of DPD-deficiency Testing in Europe. Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe. ESMO Open. 2023;8(2):101197. doi:10.1016/j.esmoop.2023.101197

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.